Best Medicare Part D Drug Plans for 2026: What to Know

If you take prescription medications — and most Medicare beneficiaries do — 2026 is one of the most important years in recent memory to review your Part D coverage. A sweeping change brought by the Inflation Reduction Act has finally taken full effect: starting January 1, 2026, no Medicare Part D enrollee will pay more than $2,000 out of pocket for covered prescription drugs in a single calendar year. That cap, which was phased in over several years, fundamentally changes the math on how you should evaluate drug plans, and it makes choosing the right plan more nuanced than ever.

Before this cap existed, beneficiaries who took expensive specialty medications — think cancer drugs, biologics for rheumatoid arthritis, or multiple sclerosis treatments — could face catastrophic drug costs exceeding $10,000 or more in a single year. The old "donut hole" coverage gap, while partially patched over the years, still left many people exposed. The new $2,000 hard cap eliminates that catastrophic exposure entirely. However, this does not mean all Part D plans are now equal. The cap applies to your out-of-pocket spending, but the path to reaching it — your deductible, your copays, your coinsurance at each tier — varies dramatically from plan to plan. A plan with a high deductible and steep tier-3 copays will drain your wallet faster on the way to that $2,000 ceiling than a plan with richer cost-sharing.

For 2026, the standard Part D deductible is set at $590, up from $545 in 2025. Not every plan charges the full deductible — some waive it entirely for lower tiers, meaning generic drugs may be covered from day one without you first paying hundreds of dollars out of pocket. When comparing plans on Medicare's Plan Finder tool at Medicare.gov, pay close attention to whether the deductible applies to all drug tiers or only tiers 3 through 5. If most of your medications are generics (tier 1 or tier 2), a plan that waives the deductible on those tiers can save you real money even if its monthly premium is slightly higher than a competitor's.

Premiums for standalone Part D plans in 2026 range from as low as $0 per month in some regions to well over $100 per month for plans with broader formularies or lower cost-sharing. The national base beneficiary premium for 2026 is approximately $36.78 per month, though what you actually pay depends on the specific plan you choose and where you live. High-income beneficiaries also pay an Income-Related Monthly Adjustment Amount, or IRMAA, on top of their plan premium. In 2026, IRMAA surcharges for Part D range from roughly $13.70 to $85.80 per month depending on your income bracket, based on your 2024 tax return. If your income dropped significantly due to retirement, divorce, or death of a spouse, you can request a reconsideration using IRS Form SSA-44.

The five largest Part D plan sponsors by enrollment heading into 2026 are UnitedHealthcare (AARP-branded plans), CVS Health (Aetna and SilverScript), Humana, Cigna-Evernorth, and Centene (WellCare). Each of these carriers offers multiple plan variants at different price points, and their formularies — the lists of covered drugs — differ in ways that matter enormously depending on what you take. For example, one carrier's basic plan may cover your brand-name blood thinner at tier 3 with a $47 copay, while a competitor places the same drug on tier 4 with 25% coinsurance after the deductible. Over 12 fills, that difference can easily exceed $300 to $500 annually. This is why the Medicare Plan Finder tool, which allows you to enter your exact medications and compare your estimated annual costs across every plan available in your ZIP code, is the single most valuable resource available to you during enrollment.

The Annual Enrollment Period for 2026 coverage ran from October 15 through December 7, 2025. If you missed that window and are currently enrolled in a Part D plan, you generally cannot switch until the next AEP unless you qualify for a Special Enrollment Period. Common SEP triggers include moving to a new address outside your plan's service area, losing other creditable drug coverage, or qualifying for Extra Help. The Medicare Open Enrollment Period, which runs January 1 through March 31 each year, does allow Part D enrollees to switch standalone drug plans once — a lesser-known option that many beneficiaries overlook. If your current plan's formulary changed at the start of 2026 and your drug costs jumped, the OEP may give you a chance to move to a better-fitting plan with a coverage start date of the first of the following month.

The Medicare Extra Help program — also called the Low Income Subsidy — deserves special attention in 2026. Beneficiaries who qualify receive dramatically reduced premiums, deductibles, and copays on Part D coverage. Full Extra Help recipients in 2026 pay no more than $4.50 for generic drugs and $11.20 for brand-name drugs per fill. Eligibility is based on income and assets: individuals with income up to 150% of the federal poverty level and limited assets may qualify. For 2026, that translates to roughly $21,500 in annual income for an individual. The Social Security Administration handles Extra Help applications, which you can submit at ssa.gov or by calling 1-800-772-1213. If you were denied Extra Help in a prior year, it is worth reapplying, as income and asset thresholds are updated annually and your financial situation may have changed.

One strategic consideration that many beneficiaries miss: if you are enrolled in a Medicare Advantage plan that includes Part D drug coverage (called an MA-PD plan), you cannot also enroll in a standalone Part D plan. Your drug coverage is bundled into your Advantage plan, and the formulary is set by that plan's carrier. If your MA-PD plan's drug coverage is inadequate for your needs, your primary option is to switch to a different Medicare Advantage plan with better drug coverage during AEP, or to disenroll from Medicare Advantage entirely and return to Original Medicare paired with a standalone Part D plan. Disenrolling from Medicare Advantage during the OEP (January 1 through March 31) allows you to return to Original Medicare and enroll in a Part D plan, though Medigap coverage at that point may require medical underwriting depending on your state.

When evaluating any Part D plan, look beyond the star rating and the premium. Check whether your pharmacy — including any mail-order pharmacy you use — is in the plan's preferred network. Using a preferred network pharmacy can reduce your copays by $5 to $15 per fill compared to a standard in-network pharmacy. For someone filling six to eight prescriptions monthly, that difference adds up to hundreds of dollars per year. Also verify that your specific drug dosage and formulation is covered — formularies list drugs by name but sometimes restrict coverage to specific strengths or require prior authorization for certain doses. A plan that covers lisinopril 10mg may require a step-therapy process before covering the 20mg dose your doctor prescribes.

The bottom line for 2026 is this: the new $2,000 out-of-pocket cap is genuinely good news for beneficiaries with high drug costs, but it does not eliminate the need to compare plans carefully. The right plan is the one that covers your specific medications at the lowest total annual cost — premium plus deductible plus copays — at a pharmacy you can actually use. Use Medicare's Plan Finder, enter every drug you take with the correct dosage, select your preferred pharmacy, and sort by estimated annual drug cost rather than premium alone. That one step, repeated each fall during the Annual Enrollment Period, is the most powerful thing you can do to protect your prescription drug budget.